Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C
Authors:
- Namiki IzumiNINamiki Izumi
- Nobuyuki EnomotoNENobuyuki Enomoto
- Masakatsu UchiharaMUMasakatsu Uchihara
- Masayuki KurosakiMKMasayuki Kurosaki
- Yuko OnukiYOYuko Onuki
- Yuki NishimuraYNYuki Nishimura
- Ken UedaKUKen Ueda
- Kaoru TsuchiyaKTKaoru Tsuchiya
- Hiroyuki NakanishiHNHiroyuki Nakanishi
- Takatoshi KitamuraTKTakatoshi Kitamura
- Shozo MiyakeSMShozo Miyake
- 1 October 2005
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 43 (4) , 623-629
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Mechanism of action of ribavirin in the combination treatment of chronic HCV infectionHepatology, 2002
- RNA virus error catastrophe: Direct molecular test by using ribavirinProceedings of the National Academy of Sciences, 2001
- The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagenNature Medicine, 2000
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusThe Lancet, 1998
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled studyJournal of Hepatology, 1996
- A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis CGastroenterology, 1993
- Ribavirin treatment for chronic hepatitis CThe Lancet, 1991